NCT02717702

Brief Summary

Acute Coronary Syndrome (ACS) is a serious heart condition that is a leading cause of death in America. Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization (placing a tube in the heart) for coronary angiogram (invasive mapping of the blood vessels of the heart). However, stress tests require imaging by highly trained specialists and even then may not correctly categorize a small minority of patients being evaluated for ACS. Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test. The investigators seek to determine whether these blood tests can help to better identify patients with ACS. The study will also store any extra blood sample that may be left over for future use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 24, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

August 10, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2019

Completed
Last Updated

August 19, 2019

Status Verified

August 1, 2019

Enrollment Period

1.7 years

First QC Date

March 18, 2016

Last Update Submit

August 16, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • % Post Stress-Delta

    1-hour Post-Stress Troponin I - Resting Baseline Troponin I)/ Resting Baseline Troponin I

    1 hour

  • % 2-hour Stress-Delta

    (3-hour Post-Stress Troponin I - Resting Baseline Troponin I)/ Resting Baseline Troponin I

    2 hour

Secondary Outcomes (2)

  • Delta BNP values

    1hr

  • Delta BNP values

    2hr

Study Arms (1)

ACS Patients

Subjects will be patients presenting to the Emergency Department for evaluation of ACS.

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Potential participants are patients presenting to the Emergency Department for evaluation of ACS.

You may qualify if:

  • Any patient presenting to the ED with clinical suspicion of ACS as determined by the treating emergency physician. These include symptoms including but not limited to chest pain, pressure, or burning sensation across the precordium.
  • Age 40 years or older.

You may not qualify if:

  • Patient with cardiac marker diagnosis of acute myocardial infarction or who otherwise is not a candidate for a cardiac stress test.
  • Evidence of serious arrhythmias or acute MI or ischemia on ECG
  • Unstable vital signs: persistent (\> 2 readings or over 2 hours) hypotension (systolic blood pressure \< 80 mm Hg), pulse \> 110 beats per minute.
  • Any medical condition that would be worsened by cardiac stress
  • Aortic aneurysm or dissection
  • Active myocarditis or pericarditis
  • Ventricular dysrhythmia or significant atrial dysrhythmia
  • Severe or greater degree of aortic stenosis
  • Acute or decompensated heart failure or pulmonary edema
  • Pulmonary embolism
  • Aortic aneurysm
  • Patient is non-English speaking.
  • Patient is incarcerated or a prisoner.
  • Patient does not have capacity to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Acute Coronary Syndrome

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Alexander T Limkakeng, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2016

First Posted

March 24, 2016

Study Start

August 10, 2016

Primary Completion

May 7, 2018

Study Completion

June 11, 2019

Last Updated

August 19, 2019

Record last verified: 2019-08

Locations